Policy changes over the past five years or so have dramatically reshaped the global cannabis market. Not only has there been an unprecedented boom in medical markets, but following policy shifts in several jurisdictions a growing number of countries are also preparing for legal regulation of non-medical use. Such moves look set to bring a clear range of benefits in terms of health and human rights. As this groundbreaking Report, highlights, however, there are also serious concerns about the unfolding market dynamics.
TNI's Prof. Dave Bewley-Taylor recently delivered a statement on how states can reconcile treaty obligations with democratically mandated policy shifts at the national level to a legally regulated cannabis market, with due regard for international law, and what role the International Narcotics Control Board can play in this process.
Local and regional authorities across Europe are confronted with the negative consequences of a persisting illicit cannabis market. Increasingly, local and regional authorities, non-governmental pressure groups and grassroots movements are advocating a regulation of the recreational cannabis market.
The Netherlands has long been considered a leader of progressive drug policy, but it is increasingly being left behind by policy innovations outside Europe. Nonetheless Dutch cities are leading the way towards more progressive and locally adapted cannabis policies. Produced as part of a the "New Approaches in Harm Reduction Policies and Practices" project, this Country Report seeks to understand the drivers of Dutch cannabis policy today, and the possibilities for its future.
Three United Nations Conventions provide the international legal framework on drug control, instructing countries to limit drug supply and use to medical and scientific purposes. Yet, debate continues on the decriminalisation, or even legalisation, of drugs, particularly cannabis. Models under development for the legal supply of cannabis are described in this analysis, as well as some of the questions they raise.
Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.
This is a guide to regulating legal markets for the non-medical use of cannabis. It is for policy makers, drug policy reform advocates and affected communities all over the world, who are witnessing the question change from, 'Should we maintain cannabis prohibition?' to 'How will legal regulation work in practice?
Barely a week after an opinion poll showed that 65% of the Dutch are in favour of regulating cannabis production just as in Uruguay, the minister of Justice and Security of The Netherlands, Ivo Opstelten, told parliament that he will not allow regulated cannabis cultivation to supply the coffeeshops in the country. Two in three large municipal councils back regulated cannabis cultivation, but the minister will probably not allow a single one of the 25 proposals to experiment with regulated cultivation that have been submitted.
This briefing is a preliminary sketch of the legal landscape for cannabis social clubs in Spain. Its author is presently conducting legal analysis and empirical research in Spain and her findings will be published in due course. The aim of this briefing is to provide an interim sketch of the relevant law for English speakers working in drug policy.
Benedikt Fischer, Victoria Jeffries, Wayne Hall, Robin Room, Elliot Goldner, Jürgen Rehm
01 September 2011
More than one in ten adults – and about one in three young adults – report past year cannabis use in Canada. While cannabis use is associated with a variety of health risks, current policy prohibits all use, rather than adopting a public health approach focusing on interventions to address specific risks and harms as do policies for alcohol. The objective of this paper was to develop ‘Lower Risk Cannabis Use Guidelines’ (LRCUG) based on research evidence on the adverse health effects of cannabis and factors that appear to modify the risk of these harms.
Cannabis is the world’s most widely used illicit drug. But for how much longer? In a short space of time we have moved from absolute global prohibition of the drug, with the emergence of legalised and regulated production and retail not in just one nation (Uruguay) but also, surprisingly, in two US states (Colorado and Washington). Do these and other new permissive models in Spain and Belgium, for example, point to a tipping point in the debate? Could cannabis step out of the shadows and join the ranks of alcohol and tobacco, the world’s most popular legal and regulated drugs?
The European Citizens’ Initiative (ECI) is a great innovation of the Treaty of Lisbon, enabling EU citizens to call directly on the European Commission to propose a legal act, if they can obtain the support of one million of their fellow citizens. The "Weed like to talk” campaign, launched by three French university students this year, aims to collect one million signatures from at least seven EU countries to call for a common cannabis policy based on a legally regulated market.
In order to better understand the situation around, and possibilities for, local and regional cannabis regulation, a series of six country reports were developed. The country reports provide detailed information about the state of cannabis policy, and the possibilities for change, within each country. This briefing identifies some of the key findings and implications for policy makers and advocates from this research.
Cannabis (or marihuana) is one of the most widely consumed psychoactive substances in the world. According to the United Nations World Drug Report, 183 million people, or 3.8% of the world’s population, used cannabis in 2014. Its cultivation was also reported by 129 countries. Cannabis is subject to the United Nations System for International Control of Narcotic Drugs and Psychotropic Substances (hereafter “drugs”) and is the most widely consumed of all the drugs. According to that control system, cannabis is among the substances with the strictest legal status; they are the most prohibited, supposedly because of the harm they cause and their lack of medical usefulness.
The new coalition government of conservative liberals (VVD) and social-democrats (PvdA) presented its coalition agreement on Monday. They agreed to abolish the cannabis pass, but access to coffeeshops remains limited to residents of the Netherlands. Customers need to identify themselves with an identity card or a residence permit together with a certificate of residence. Non-resident foreigners are still banned. In other words, there will be no cannabis pass, but the policy continues.
The new coalition government agreed to abolish the cannabis pass, but access to coffeeshops remains limited to residents of the Netherlands. It shows all the signs of a half-baked compromise between two diametrically opposed positions.
The “Portuguese model” of drugs decriminalisation has clearly demonstrated that greater tolerance to drug users does not lead to an increase in consumption. Nevertheless it is a model with immense loopholes and contradictions.
Health officials of the Basque Country, an autonomous region of Spain, announced that they will introduce a bill to regulate the "cultivation, sale and consumption" of hashish and marijuana. The bill, which will be presented to the regional parliament next year, was put forward on December 12, 2011, by regional health officials during the presentation of the regional addictions plan. Several media outlets broke the news as an intent to legalise cannabis use, while in fact the proposed legislation only aims to regulate cannabis user associations that cultivate for personal use.